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Abstract
Importance
Interventions to transform primary care practices into medical homes are increasingly common, but their
effectiveness in improving quality and containing costs is unclear.
Objective
To measure associations between participation in the Southeastern Pennsylvania Chronic Care Initiative, one
of the earliest and largest multipayer medical home pilots conducted in the United States, and changes in the
quality, utilization, and costs of care.
Design, Setting, and Participants
Thirty-two volunteering primary care practices participated in the pilot (conducted from June 1, 2008, to May
31, 2011). We surveyed pilot practices to compare their structural capabilities at the pilot’s beginning and end.
Using claims data from 4 participating health plans, we compared changes (in each year, relative to before the
intervention) in the quality, utilization, and costs of care delivered to 64 243 patients who were attributed to
pilot practices and 55 959 patients attributed to 29 comparison practices (selected for size, specialty, and
location similar to pilot practices) using a difference-in-differences design.
Exposures
Pilot practices received disease registries and technical assistance and could earn bonus payments for
achieving patient-centered medical home recognition by the National Committee for Quality Assurance
(NCQA).
Main Outcomes and Measures
Practice structural capabilities; performance on 11 quality measures for diabetes, asthma, and preventive care;
utilization of hospital, emergency department, and ambulatory care; standardized costs of care.
Results
Pilot practices successfully achieved NCQA recognition and adopted new structural capabilities such as
registries to identify patients overdue for chronic disease services. Pilot participation was associated with
statistically significantly greater performance improvement, relative to comparison practices, on 1 of 11
investigated quality measures: nephropathy screening in diabetes (adjusted performance of 82.7% vs 71.7% by
year 3, P < .001). Pilot participation was not associated with statistically significant changes in utilization or
costs of care. Pilot practices accumulated average bonuses of $92 000 per primary care physician during the
3-year intervention.
Conclusions and Relevance
A multipayer medical home pilot, in which participating practices adopted new structural capabilities and
received NCQA certification, was associated with limited improvements in quality and was not associated
This technical report is available at ScholarlyCommons: http://repository.upenn.edu/hcmg_papers/32
with reductions in utilization of hospital, emergency department, or ambulatory care services or total costs
over 3 years. These findings suggest that medical home interventions may need further refinement.
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Association Between Participation in a Multipayer Medical
Home Intervention and Changes in Quality, Utilization,
and Costs of Care
Mark W. Friedberg, MD, MPP; Eric C. Schneider, MD, MSc; Meredith B. Rosenthal, PhD; Kevin G. Volpp, MD, PhD;
Rachel M. Werner, MD, PhD
IMPORTANCE Interventions to transform primary care practices into medical homes are
increasingly common, but their effectiveness in improving quality and containing costs is
unclear.
OBJECTIVE To measure associations between participation in the Southeastern Pennsylvania
Chronic Care Initiative, one of the earliest and largest multipayer medical home pilots
conducted in the United States, and changes in the quality, utilization, and costs of care.
DESIGN, SETTING, AND PARTICIPANTS Thirty-two volunteering primary care practices
participated in the pilot (conducted from June 1, 2008, to May 31, 2011). We surveyed pilot
practices to compare their structural capabilities at the pilot’s beginning and end. Using
claims data from 4 participating health plans, we compared changes (in each year, relative to
before the intervention) in the quality, utilization, and costs of care delivered to 64 243
patients who were attributed to pilot practices and 55 959 patients attributed to 29
comparison practices (selected for size, specialty, and location similar to pilot practices) using
a difference-in-differences design.
EXPOSURES Pilot practices received disease registries and technical assistance and could
earn bonus payments for achieving patient-centered medical home recognition by the
National Committee for Quality Assurance (NCQA).
MAIN OUTCOMES AND MEASURES Practice structural capabilities; performance on 11 quality
measures for diabetes, asthma, and preventive care; utilization of hospital, emergency
department, and ambulatory care; standardized costs of care.
RESULTS Pilot practices successfully achieved NCQA recognition and adopted new structural
capabilities such as registries to identify patients overdue for chronic disease services. Pilot
participation was associated with statistically significantly greater performance
improvement, relative to comparison practices, on 1 of 11 investigated quality measures:
nephropathy screening in diabetes (adjusted performance of 82.7% vs 71.7% by year 3,
P < .001). Pilot participation was not associated with statistically significant changes in
utilization or costs of care. Pilot practices accumulated average bonuses of $92 000 per
primary care physician during the 3-year intervention.
CONCLUSIONS AND RELEVANCE A multipayer medical home pilot, in which participating
practices adopted new structural capabilities and received NCQA certification, was associated
with limited improvements in quality and was not associated with reductions in utilization of
hospital, emergency department, or ambulatory care services or total costs over 3 years.
These findings suggest that medical home interventions may need further refinement.
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P rofessional associations, payers, policy makers, andother stakeholders have advocated the patient-centered medical home, a team-based model of pri-
mary care practice intended to improve the quality, effi-
ciency, and patient experience of care.1,2 In general, medical
home initiatives have encouraged primary care practices to
invest in patient registries, enhanced access options, and
other structural capabilities in exchange for enhanced
payments—often operationalized as per-patient per-month
fees for comprehensive care services.3,4 Dozens of privately
and publicly financed medical home pilots are under way,
and most use recognition by the National Committee for
Quality Assurance (NCQA) to assess practice structural
capabilities.4,5
Recent evidence reviews suggest that early “medical
home” interventions have yielded modest improvements at
best in quality and patient experience, with little evidence of
effects on costs of care.6-8 However, these reviews included
studies that preceded development of NCQA medical home
recognition criteria and lacked significant financial support
from payers, potentially limiting their applicability to cur-
rent medical home efforts.9,10 More recent evaluations have
assessed medical home pilots including only 1 payer (poten-
tially a small fraction of some practices’ patient panels)
occurring over a 1- or 2-year time frame (possibly insufficient
to observe effects requiring longer time frames),11-13 or
within large, integrated delivery systems atypical of most
primary care practices.14,15 We hypothesized that a multi-
payer medical home initiative involving a longer interven-
tion period and substantial financial support would be more
likely to be associated with measurable improvements in
quality and efficiency.
Methods
We evaluated associations between implementation of the
Pennsylvania Chronic Care Initiative (PACCI), a statewide mul-
tipayer medical home pilot, and changes in the quality, utili-
zation, and cost of care. This study was approved by the RAND
human subjects protection committee and the University of
Pennsylvania institutional review board, with implied in-
formed consent for practice structural surveys and waived con-
sent for analyses of deidentified claims data.
Pilot Design
The pilot was initiated in Pennsylvania’s southeast region
among volunteering small- and medium-sized primary care
practices from June 1, 2008, to May 31, 2011. As detailed
elsewhere,16,17 the PACCI was designed by a coalition of pay-
ers, clinicians, and delivery systems led by the Governor’s Of-
fice of Health Care Reform and implemented as a series of re-
gional medical home pilots, beginning with the southeast
region.
Practices in southeast Pennsylvania were invited to par-
ticipate by the 6 health plans (3 commercial and 3 Medicaid
managed care plans) and 3 professional organizations (the
Pennsylvania Academy of Family Physicians, American Col-
lege of Physicians, and American Academy of Pediatrics) par-
ticipating in the PACCI, with the goal of enrolling a mix of prac-
tice sizes and specialties (family practice, internal medicine,
pediatric, and nurse-managed health centers).
The intervention consisted of technical assistance
including a Breakthrough Series Learning Collaborative,18
web-based Improving Performance in Practice (IPIP) disease
registries to create monthly quality indicator reports,19 and
assistance from IPIP practice coaches to facilitate practice
transformation and achievement of NCQA Physician Prac-
tice Connections–Patient-Centered Medical Home (PPC-
PCMH) recognition (with level 1 recognition required by the
second pilot year).20 Performance improvement efforts tar-
geted asthma for pediatric practices and diabetes for prac-
tices serving adults.
To support and motivate these improvements, each par-
ticipating practice was eligible to receive a $20 000 “practice
support” payment in year 1 and annual bonus payments per
full-time equivalent clinician (ie, per physician or nurse prac-
titioner) that varied based on NCQA medical home recogni-
tion level and practice size, ranging from $28 000 per clini-
cian in NCQA level 1 practices with 10 to 20 clinicians to $95 000
per clinician in solo NCQA level 3 practices.
Comparison Practices
Within 3 months of recruiting pilot practices, the state se-
lected comparison practices. To do this, a state contractor ob-
tained lists of candidate practices from participating health
plans and, without performing a strict 1-to-1 match, identi-
fied a group of comparison practices that had the same ap-
proximate composition as the pilot practices in practice size,
specialty (pediatrics, family practice, internal medicine), lo-
cation (urban, suburban), and affiliation with local health sys-
tems. Data on quality, utilization, and costs were unavailable
for comparison practice selection.
Pilot Data, Practice Survey, and Claims Data
We obtained, from Pennsylvania’s demonstration conveners,
annual data on each pilot practice’s level of NCQA PPC-PCMH
recognition (none or level 1, 2, or 3) and amounts of each pilot
practice’s bonus payments.
Drawing from a survey instrument designed to assess prac-
tice readiness for the medical home,21 we devised a new sur-
vey to measure practices’ structural capabilities, including pres-
ence of performance feedback, disease management, registries,
reminder and outreach systems for patients with chronic dis-
ease, and electronic health records (EHRs) (instrument avail-
able from authors on request).
We fielded the practice survey twice to each pilot and com-
parison practice: a “baseline” survey in September 2010, que-
rying capabilities just prior to June 2008 (the pilot’s begin-
ning), and a final survey in June 2011, querying capabilities at
the pilot’s end. We addressed each survey to 1 leader per prac-
tice, identified by telephone call, who could report accu-
rately on the practice’s structural capabilities.
We requested from each of the 6 participating health plans
all medical and prescription drug claims and enrollment data
spanning June 1, 2006, to May 30, 2011 (2 years prior to and 3
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years after the pilot inception date of June 1, 2008), for their
members who, at any time during this 5-year period, had 1 or
more medical claims (for any service) with a pilot or compari-
son practice.
Patient Attribution
In each of 4 time periods (the preintervention period and in-
tervention years 1, 2, and 3), we attributed patients to the pri-
mary care clinicians (specialty designations family practice,
general practice, internal medicine, pediatrics, adolescent
medicine, geriatric medicine, and nurse practitioner) who pro-
vided the plurality of qualifying services (Current Procedural
Terminology codes 9920x, 9921x, 9924x, 99381-99387, 99391-
99397, 99401-99404, 99411-99412, 99420-99429, 99339-
99340, 99341-99345, 99347-99350, G0402, G0438, G0439), with
the most recent service breaking ties. In sensitivity analyses,
we reattributed patients based on the majority (>50%) of quali-
fying services.
Measures of Quality, Utilization, and Costs
We c a l c u l ate d c l a i m s - b a s e d p r o c e s s m e a s u r e s o f
quality using NCQA Healthcare Effectiveness and Data
Information Set (HEDIS) specifications, following published
recommendations22 and making adjustments as necessary
to account for the limited available look-back period. Using
laboratory data available from one commercial health plan,
we also calculated 2 measures of diabetes control, also
based on HEDIS specifications.
To measure utilization, we calculated rates of hospitaliza-
tion (all-cause), emergency department (ED) visits (all-
c ause), and ambulator y visits following published
recommendations.23 We also calculated rates of ambulatory
care–sensitive hospitalizations and ED visits, because these
may be more likely to represent avoidable (and potentially
wasteful) resource utilization, relative to all-cause hospital-
izations and ED visits. Because health care prices can be sen-
sitive to local market factors, we calculated standardized prices
for all claims using Optum normalized pricing software.24 The
eAppendix in the Supplement presents measure specifica-
tions.
Statistical Analyses
We compared pilot and comparison practices and their prein-
tervention patient populations using Wilcoxon rank sum and
Fisher exact tests. To characterize pilot practices’ adoption of
structural capabilities, we compared baseline and postinter-
vention rates of capability possession (eg, rates at which prac-
tices had EHRs) using Liddell exact tests to account for re-
peated measurements, excluding 3 practices that did not
respond to both surveys.
To mitigate the potential influence of patient selection
(which could in theory be induced by pilot participation), in
our main analyses we assigned patients to practices based on
preintervention attribution only. Under this intent-to-treat
framework, any patients switching their primary care physi-
cians (ie, becoming attributed to another practice) during the
intervention would still be attributed to their preinterven-
tion practices for analysis. Two potential drawbacks of prein-
tervention attribution are nondetectability of interventions tar-
geting patients new to a practice (eg, enhanced patient intake
procedures) and potential confounding by time-varying pat-
terns of health care consumption.25 Therefore, we performed
sensitivity analyses using sequential cross-sectional attribu-
tion (ie, reattributing patients in each year based on their vis-
its in that year) to assign patients.
To evaluate associations between the PACCI intervention
and changes in quality measure performance, we fit general-
ized logistic models using propensity weights to balance pilot
and comparison practices’ shares of patients from each
health plan and baseline performance on each measure. By
giving more weight to observations from comparison prac-
tices whose baseline performance resembled that of pilot
practices, this weighting method produced “average treat-
ment effect on the treated” (ATT) estimates, answering the
question: “Among practices closely resembling the pilot prac-
tices, what changes are associated with the intervention?”26
The dependent variable in each model was patient-level
receipt of the indicated service, and independent variables
were indicators for time period (preintervention and each
intervention year), interactions between time period and
pilot/comparison status, indicators for the health plan con-
tributing each observation and patient enrollment in a health
maintenance organization (HMO), and fixed effects (dummy
variables) for each practice.
For measures of utilization, we fit negative binomial mod-
els, using ATT propensity weighting to balance health plans
and baseline utilization rates. The dependent variable in each
model was the utilization count in the time period of interest.
Independent variables were indicators for time period (pre-
intervention and each intervention year); interaction be-
tween time period and pilot/comparison status; indicators for
the health plan contributing each observation and patient en-
rollment in an HMO; patient age, sex, and preintervention
Charlson comorbidity score27; and practice fixed effects. In sen-
sitivity analyses, we refit the utilization models using 2-part
models (logistic and negative binomial).
For measures of cost, we fit propensity-weighted models
with the same independent variables but used a linear func-
tional form, following the methods of recent similar
evaluations.28 In sensitivity analyses, we refit the cost mod-
els using log-transformed costs.29
We also identified patients who had multiple all-cause hos-
pitalizations or ED visits (2 visits or ≥3 visits) within a single
year. We then fit logistic models to identify pilot-associated
changes in the prevalence of these “multiple use” patients,
using the same independent variables as the other utilization
models.
In all models, we used generalized estimating equations
with robust standard errors to account for heteroscedasticity,
autocorrelation, and clustering of patients within practices.30,31
Because these methods can be sensitive to missing data, which
are created when patients change health plans, we included
only health plan members who were continuously enrolled
during the study period in our main models. However, be-
cause of small numbers of patients contributing observations
for hemoglobin A1c and low-density lipoprotein cholesterol con-
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trol and pediatric asthma controller medication use, models
for these measures included patients lacking continuous en-
rollment.
To display adjusted performance data, we used recycled
prediction methods, which allow estimates of associations
on the original scale of the data, accounting for differences
in covariate patterns between pilot and comparison
practices.32,33
We conducted sensitivity analyses in addition to those de-
scribed herein. We repeated our analyses using a plan-by-
plan basis, excluding nurse-managed health centers (be-
cause no comparison practices were in this category), and
including health plan members who were not continuously en-
rolled during the study period. Because reductions in utiliza-
tion and costs of care might be more achievable and detect-
able among patients with chronic illness and diabetes was
targeted by the PACCI, we repeated our utilization and cost
models among only patients with diabetes.34
We considered 2-tailed P values <.05 significant. We per-
formed data management and analyses using SAS version 9.2
(SAS Institute), SQL Server 2008 (Microsoft), and R version 3.0.0
(R Foundation).
Results
All 34 volunteering practices were admitted to the pilot, but 2
withdrew prior to its initiation (ie, before receiving any assis-
tance or supplemental funding) for reasons unrelated to the
pilot (office manager illness in 1 practice and key staff mem-
ber departure in the other). All 32 remaining practices com-
pleted the pilot; none dropped out. The 6 participating health
plans together accounted for the majority of total revenues (me-
dian, 65%) among pilot practices.
The 32 pilot and 29 comparison practices were similar in
baseline size, specialty, and patient case mix (Table 1). How-
ever, 6 pilot practices were nurse-managed health centers,
whereas no comparison practices were. In total, 64 243 pa-
tients were attributed to pilot practices and 55 959 to compari-
son practices in the preintervention period.
Twenty-nine pilot practices (91%) completed both the base-
line and year 3 structural surveys. A low survey response rate
(24%) among comparison practices precluded meaningful
analysis of comparison practices’ structural capabilities.
All of the pilot practices achieved NCQA PPC-PCMH rec-
ognition by the third intervention year, with half achieving level
3 status (Table 2). Pilot practices accumulated average bo-
nuses of $92 000 per primary care physician and reported struc-
tural transformation on a wide range of capabilities. For ex-
ample, use of registries to identify patients overdue for chronic
disease services increased from 30% to 85% of pilot practices
(P < .001), and electronic medication prescribing increased
from 38% to 86% (P = .001).
Four of the 6 health plans (the largest 2 commercial
and largest 2 Medicaid plans) supplied claims data. One of
these 4 plans was unable to supply claims dated prior to
Table 1. Baseline Characteristics of Pilot and Comparison Practices
Pilot
(32 Practices, 64 243
Attributed Patients)
Comparison
(29 Practices, 55 959
Attributed Patients) P Valuea
No. of PCPs, median (IQR) 5 (4-6) 4 (3-8) .99
Main specialty, No.
Family practice 16 16
.91Internal medicine 9 7
Pediatrics 7 6
Location, No.
Urban 30 27
.99
Suburban 2 2
Nurse-managed health center, No. 6b 0 .03
Patient panel characteristics,
median (IQR)c
No. of attributed patients
per practice
1245 (481-2245) 1291 (875-2471) .70
Female sex, % 58 (50-68) 52 (50-59) .15
Age among adults, y 44 (30-57) 44 (28-56) .54
Diabetes, % 7 (5-9) 6 (3-9) .51
Asthma, % 2 (1-4) 2 (1-4) .89
Practice Charlson score,
mean (IQR)
1.00 (0.71-1.42) 1.02 (0.49-1.48) .77
Insurance type, median (IQR), %
Commercially insured, % 65 (27-98) 39 (19-98) .94
Health plan A, commercial 18 (6-51) 13 (3-32) .14
Health plan B, commercial 28 (11-45) 25 (8-71) .64
Health plan C, Medicaid 23 (2-61) 33 (2-73) .82
Health plan D, Medicaidd 0 (0-74) 0 (0-90) .75
Abbreviations: IQR, interquartile
range; PCP, primary care physician or
clinician (including MDs, DOs, and
nurse practitioners).
a Wilcoxon rank sum test for counts,
percentages, and other continuous
variables; Pearson χ2 and Fisher
exact tests for categorical variables.
Note: all variables are calculated at
the practice level.
b Five of the nurse-managed health
centers had patient panels
resembling family practices
(22%-52% pediatric); the sixth had
no pediatric patients.
c Calculated at the practice level
among patients attributed to study
practices in the preintervention
period based on plurality of
qualifying visits.
d Mininum-maximum reported rather
than IQR because the IQR is (0-0).
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Table 2. NCQA Recognition, Financial Bonuses, and Selected Structural Changes Among Pilot Practices
No. of Practices
Contributing
Data
Baseline, No. (%)
of Practicesa Pilot Year 3, No. (%) P Valueb
NCQA recognition level
1 32 NAc 13 (41) NA
2 32 NA 3 (9) NA
3 32 NA 16 (50) NA
Financial bonus per PCP, mean (range) 32 NAd $92 000
($19 000-$164 000)
NA
Performance feedback
Quality feedback to PCPs 29 9 (31) 23 (79) <.001
Utilization or cost feedback to PCPs 29 11 (38) 15 (52) .22
Monthly or more frequent meetings about quality 29 8 (28) 21 (72) <.001
Monthly or more frequent meetings about utilization 28 8 (29) 11 (39) .55
Use of registry for patients
Overdue for screening services 26 9 (35) 16 (62) .07
Overdue for chronic disease services 27 8 (30) 23 (85) <.001
Out of target range for chronic disease laboratory values 26 5 (19) 18 (69) .001
At high risk of disease complications or hospitalization 29 3 (10) 27 (93) <.001
Care management for patients
At high risk of disease complications or hospitalization 29 3 (10) 27 (93) <.001
Help in better managing their diabetese 24 14 (58) 23 (96) .004
Help in better managing their asthmae 28 14 (50) 21 (75) .09
Routine assessment of self-management needs in chronic
illness
28 3 (11) 16 (57) .001
Referral system for linking to community programs 29 16 (55) 22 (76) .11
Outreach systems to contact patients due for services
Breast cancer screen 23 6 (26) 16 (70) .002
Cervical cancer screen 23 7 (30) 13 (57) .07
Colorectal cancer screen 23 5 (22) 14 (61) .01
Diabetes: hemoglobin A1c test 24 6 (25) 19 (79) <.001
Diabetes: cholesterol test 24 6 (25) 19 (79) <.001
Diabetes: eye examination 24 5 (21) 18 (75) <.001
Diabetes: nephropathy monitoring 24 5 (21) 17 (74) <.001
After hospitalization 29 6 (21) 27 (93) <.001
No appointment for extended periodf 29 13 (45) 21 (72) .06
EHR capabilities
Patient medication lists 29 17 (59) 27 (93) .002
Patient problem lists 29 17 (59) 26 (90) .004
Consultation notes from specialists 29 15 (52) 22 (76) .02
Hospital discharge summaries 29 17 (59) 22 (76) .13
Electronic medication prescribing 29 11 (38) 25 (86) .001
Electronic laboratory test ordering 29 10 (34) 23 (79) <.001
Electronic radiology test ordering 28 7 (25) 11 (39) .22
Alerts if ordered tests are not performed 27 6 (22) 11 (41) .18
Secure messaging to and from patients 29 4 (14) 13 (45) .004
Access
Weekend care offered regularly 29 18 (62) 20 (69) .63
Evening care offered ≥2 nights per wk 29 20 (69) 21 (72) .99
Appointments for new patients within 2 wk 28 13 (46) 20 (71) .04
Abbreviations: EHR, electronic health record; NA, not applicable; NCQA,
National Committee for Quality Assurance; PCP, primary care physician or
clinician (including MDs, DOs, and nurse practitioners).
a Because of item nonresponse, denominators for percentages are not the same
for all entries in the table.
b Liddell exact test.
c No practice had submitted an NCQA recognition application at baseline (ie,
prior to the start of the pilot).
d Cumulative over the 3-year pilot and calculable only in pilot year 3.
e Provided by specially trained nonphysician staff.
f Longer than clinically appropriate.
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Table 3. Propensity-Weighted, Adjusted Quality-of-Care Differences Between Pilot and Comparison Practices Among Continuously Enrolled Patients
No. of Eligible
Patients
No. (%)a
Preintervention Year 1 Year 2 Year 3
HbA1c testing
Pilot 1079 919 (85.2) 920 (85.3) 952 (88.2) 950 (88.0)
Comparison 606 516 (85.2) 534 (88.2) 528 (87.1) 502 (82.8)
% Difference (95% CI) NAb −3.0
(−8.5 to 2.5)
1.1
(−5.8 to 8.0)
5.2
(−0.8 to 11.2)
P value NA .29 .75 .09
HbA1c abnormal
Pilot 582 112 (19.2) 105 (18.1) 119 (20.4) 104 (17.9)
Comparison 175 34 (19.2) 26 (14.8) 26 (14.7) 18 (10.3)
% Difference (95% CI) NA 3.3
(−6.6 to 13.2)
5.6
(−4.8 to 16.1)
7.5
(−1.4 to 16.4)
P value NA .51 .29 .10
LDL-C testing
Pilot 1079 880 (81.6) 878 (81.4) 905 (83.9) 906 (84.0)
Comparison 606 494 (81.6) 501 (82.6) 491 (81.0) 479 (79.0)
% Difference (95% CI) NA −1.3
(−7.3 to 4.8)
2.9
(−4.8 to 10.7)
5.0
(−0.4 to 10.4)
P value NA .68 .46 .07
LDL-C abnormal
Pilot 582 199 (34.2) 191 (32.8) 176 (30.3) 201 (34.6)
Comparison 175 60 (34.2) 54 (30.7) 47 (26.9) 62 (35.2)
% Difference (95% CI) NA 2.1
(−8.7 to 12.8)
3.4
(−11.2 to 18.0)
−0.6
(−22.4 to 21.3)
P value NA .72 .63 .97
Nephropathy monitoring
Pilot 1079 786 (72.8) 842 (78.0) 875 (81.1) 892 (82.7)
Comparison 606 441 (72.8) 440 (72.6) 444 (73.3) 435 (71.7)
% Difference (95% CI) NA 5.5
(0.5 to 10.5)
7.8
(3.0 to 12.3)
11.0
(5.6 to 16.3)
P value NA .03 .002 <.001
Eye examinations
Pilot 1079 447 (41.4) 507 (47.0) 519 (48.1) 531 (49.2)
Comparison 606 251 (41.4) 261 (43.0) 273 (45.0) 277 (45.7)
% Difference (95% CI) NA 4.0
(−0.4 to 8.3)
3.1
(−4.8 to 11.0)
3.5
(−3.7 to 10.7)
P value NA .07 .45 .33
Asthma appropriate medi-
cation, pediatric
Pilot 603 543 (90.1) 546 (90.5) 535 (88.7) 541 (89.8)
Comparison 820 739 (90.1) 794 (96.8) 813 (99.1) 816 (99.5)
% Difference (95% CI) NAb −6.4
(−13.4 to 0.7)
−10.4
(−25.2 to 4.4)
−9.7
(−22.4 to 3.1)
P value NA .08 .17 .14
Breast cancer screening
Pilot 4330 2416 (55.8) 2988 (69.0) 3079 (71.1) 3057 (70.6)
Comparison 2804 1565 (55.8) 1890 (67.4) 1971 (70.3) 1943 (69.3)
% Difference (95% CI) NA 1.6
(−1.4 to 4.6)
0.7
(−3.5 to 5.0)
1.3
(−3.9 to 6.5)
P value NA .29 .73 .62
Cervical cancer screening
Pilot 2549 1700 (66.7) 1876 (73.6) 1998 (78.4) 1917 (75.2)
Comparison 1710 1141 (66.7) 1277 (74.7) 1332 (77.9) 1300 (76.0)
% Difference (95% CI) NA −1.1
(−3.9 to 1.7)
0.5
(−3.3 to 4.3)
−0.8
(−6.7 to 5.1)
P value NA .43 .79 .79
(continued)
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January 1, 2007, limiting the effective study window
to January 1, 2007, to May 30, 2011, for analyses of pooled
claims data.
Of the 11 quality measures evaluated, pilot participation
was significantly associated with greater performance
improvement on 1 measure: nephropathy monitoring in dia-
betes (Table 3). Point estimates suggested improved perfor-
mance among pilot practices relative to comparison prac-
tices for other diabetes measures and for colorectal cancer
screening, but these differences were not statistically sig-
nificant.
Pilot participation was associated with a greater increase
in the rate of ambulatory care–sensitive hospitalization, rela-
tive to comparison practices, in intervention year 2 (Table 4).
There were no other statistically significant differences in mea-
sures of utilization, costs of care, or rates of multiple same-
year hospitalizations or ED visits (Table 5).
The results of sensitivity analyses were consistent with the
primary results with 3 exceptions. First, in models including
patients who were not continuously enrolled, pilot participa-
tion was statistically significantly associated with better per-
formance for colorectal cancer screening. Second, in models
with cross-sectional attribution, pilot participation was sta-
tistically significantly associated with worse performance on
pediatric asthma appropriate medication use. Third, pilot par-
ticipation was not statistically significantly associated, in any
year, with ambulatory care–sensitive hospitalization rates in
models with cross-sectional attribution and in models includ-
ing patients lacking continuous enrollment.
Discussion
Despite widespread enthusiasm for the medical home con-
cept, few peer-reviewed publications have found that trans-
forming primary care practices into medical homes (as
defined by common recognition tools and in typical practice
settings) produces measurable improvements in the quality
and efficiency of care.6-8 The southeast region of the PACCI,
which featured relatively generous financial support from 6
commercial and Medicaid health plans, is to our knowledge
the first multipayer pilot in the nation to report results over
a 3-year period of transformation. We found that practices
participating in the PACCI pilot adopted new structural
capabilities and received NCQA certification as medical
homes. Our evaluation also suggests that the quality of
diabetes care improved, but we found few statistically sig-
nificant results and no robust associations with utilization
or costs.
Our findings differ with prior evaluations of demonstra-
tions in large, integrated delivery systems14,15,35 and with
cross-sectional studies that lacked an intervention.36,37
However, the southeast PACCI contained ingredients
common to many current pilots, including an emphasis
on NCQA recognition.4 Our findings are congruent with
those of medical home interventions occurring among
small primary care practices, even though the PACCI inter-
vention included more participating practices, occurred
over a longer time frame, and featured greater financial
support.11-13,38,39
Why was the PACCI southeast regional pilot not associ-
ated with broad quality improvements, lower utilization,
and cost savings? This pilot—the first of the PACCI regions—
was focused on quality improvement for chronic conditions
and featured early financial rewards for NCQA recognition,
possibly distracting from other activities intended to
improve the quality and efficiency of care. In subsequent
regions, PACCI organizers placed less emphasis on early
NCQA recognition so that practices could focus more fully
on learning collaborative participation (oral communication
with Michael Bailit, MM, Bailit Health Purchasing, Novem-
ber 26, 2010).
Table 3. Propensity-Weighted, Adjusted Quality-of-Care Differences Between Pilot and Comparison Practices Among Continuously Enrolled Patients
(continued)
No. of Eligible
Patients
No. (%)a
Preintervention Year 1 Year 2 Year 3
Chlamydia screening
Pilot 521 180 (34.6) 200 (38.3) 226 (43.3) 249 (47.7)
Comparison 521 180 (34.6) 205 (39.3) 247 (47.4) 247 (47.4)
% Difference (95% CI) NA −1.0
(−7.0 to 4.9)
−4.2
(−10.2 to 1.9)
0.3
(−5.9 to 6.5)
P value NA .74 .18 .92
Colorectal cancer screening
Pilot 4949 1965 (39.7) 2361 (47.7) 2722 (55.0) 2722 (55.0)
Comparison 3493 1387 (39.7) 1579 (45.2) 1816 (52.0) 1764 (50.5)
% Difference (95% CI) NA 2.6
(−0.4 to 5.6)
3.1
(−1.0 to 7.1)
4.3
(−3.9 to 12.9)
P value NA .09 .14 .30
Abbreviations: LDL-C, low-density lipoprotein cholesterol; NA, not applicable.
a Percentage point estimates are propensity-weighted recycled predictions
from linear probability models adjusting for practice baseline score, health
plan contributing each observation, and whether each patient was in a health
maintenance organization at the time of the observation. Frequencies are
calculated from adjusted, weighted percentages based on the denominators
for each measure. Differences, CIs, and P values correspond to marginal
differences from the linear probability models.
b Because of the inclusion of fixed effects for practices, regression models do
not estimate preintervention differences between pilot and comparison.
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Table 4. Propensity-Weighted, Adjusted Differences in Utilization and Costs of Care Between Pilot and Comparison Practices Among Continuously
Enrolled Patients (n=39559 Pilot and n=40234 Comparison Patients)
No. (Rate per 1000 Patients per mo) [95% CI]a
Preintervention Year 1 Year 2 Year 3
Hospitalizations, all-cause
Pilot 479 (12.1)
[9.4 to 14.8]
435 (11.0)
[7.3 to 14.7]
435 (11.0)
[7.4 to 14.6]
427 (10.8)
[7.1 to 14.5]
Comparison 489 (12.1)
[9.3 to 14.9]
394 (9.8)
[7.3 to 12.3]
398 (9.9)
[7.4 to 12.4]
386 (9.6)
[7.1 to 12.1]
Difference (95% CI)b NAc 1.2 (−0.9 to 3.8) 1.1 (−1.1 to 3.9) 1.2 (−1.2 to 4.4)
P value NA .30 .36 .36
Hospitalizations, ambulatory care–sensitive
Pilot 67 (1.7)
[1.3 to 2.1]
71 (1.8)
[1.4 to 2.2]
83 (2.1)
[1.6 to 2.6]
83 (2.1)
[1.6 to 2.6]
Comparison 68 (1.7)
[1.1 to 2.3]
64 (1.6)
[1.1 to 2.1]
68 (1.7)
[1.2 to 2.2]
72 (1.8)
[1.4 to 2.2]
Difference (95% CI)b NA 0.2 (−0.1 to 0.7) 0.4 (0.1 to 0.8) 0.3 (−0.3 to 1.0)
P value NA .20 .007 .33
ED visits, all-cause
Pilot 1646 (41.6)
[31.3 to 51.9]
1839 (46.5)
[34.0 to 59.0]
1851 (46.8)
[34.2 to 59.4]
1745 (44.1)
[31.9 to 56.3]
Comparison 1673 (41.6)
[29.7 to 53.5]
1867 (46.4)
[34.4 to 58.4]
1854 (46.1)
[34.5 to 57.7]
1698 (42.2)
[31.9 to 52.5]
Difference (95% CI)b NA 0.1 (−3.2 to 3.8) 0.7 (−3.2 to 5.0) 1.9 (−3.1 to 7.5)
P value NA .94 .73 .47
ED visits, ambulatory care–sensitive
Pilot 1100 (27.8)
[19.9 to 35.7]
1187 (30.0)
[20.6 to 39.4]
1163 (29.4)
[20.0 to 38.8]
1092 (27.6)
[18.4 to 36.8]
Comparison 1119 (27.8)
[18.7 to 37.0]
1155 (28.7)
[19.9 to 37.5]
1123 (27.9)
[29.5 to 36.3]
1006 (25.0)
[17.5 to 32.5]
Difference (95% CI)b NA 1.3 (−1.4 to 4.3) 1.5 (−2.1 to 5.5) 2.6 (−1.7 to 7.7)
P value NA .35 .43 .25
Ambulatory visits, primary care
Pilot 6496 (164.2)
[142.0 to 186.4]
6045 (152.8)
[123.0 to 182.6]
5993 (151.5)
[120.0 to 183.0]
5811 (146.9)
[117.3 to 176.5]
Comparison 6606 (164.2)
[144.2 to 184.2]
6047 (150.3)
[132.9 to 167.7]
5975 (148.5)
[132.2 to 164.8]
5717 (142.1)
[127.0 to 157.2]
Difference (95% CI)b NAc 2.5 (−0.9 to 5.4) 2.9 (−2.4 to 7.4) 4.8 (−1.7 to 10.5)
P value NA .14 .27 .14
Ambulatory visits, specialist
Pilot 2010 (50.8)
[24.8 to 76.8]
2496 (63.1)
[34.8 to 91.4]
2623 (66.3)
[36.4 to 96.2]
2556 (64.6)
[36.0 to 93.2]
Comparison 2044 (50.8)
[18.6 to 83.0]
2639 (65.6)
[29.1 to 102.1]
2772 (68.9)
[29.9 to 107.9]
2740 (68.1)
[30.7 to 105.5]
Difference (95% CI)b NA −2.4 (−3.8 to 1.4) −2.6 (−4.5 to 1.8) −3.5 (−6.4 to 3.0)
P value NA .57 .21 .40
Total costs of care, $d
Pilot 389.0 (304.1 to 474.6) 417.8 (307.5 to 529.7) 440.2 (313.3 to 566.9) 430.3 (302.7 to 556.3)
Comparison 389.0 (317.5 to 458.9) 382.4 (300.0 to 460.1) 407.2 (314.1 to 494.0) 395.2 (303.0 to 480.2)
Difference (95% CI) NA 35.4 (−7.7 to 78.5) 33.0 (−10.4 to 76.4) 35.1 (−22.3 to 92.5)
P value NA .11 .14 .23
Abbreviations: ED, emergency department; NA, not applicable.
a Point estimates are propensity-weighted recycled predictions from negative
binomial regression models adjusting for baseline utilization rates; patient sex,
age, and Charlson comorbidity score; health plan contributing each
observation; and whether each patient was in a health maintenance
organization at the time of the observation. Frequencies are calculated from
adjusted, weighted percentages based on the denominators for each
measure. Differences, CIs, and P values represent marginal differences from
these models.
b Difference per 1000 patients per month.
c Because of the inclusion of fixed effects for practices, regression models do
not estimate preintervention differences between pilot and comparison.
d Point estimates and CIs for cost are propensity-weighted recycled predictions
from linear models adjusting for baseline costs of care; patient sex, age, and
Charlson comorbidity score; health plan contributing each observation; and
whether each patient was in a health maintenance organization at the time of
the observation. Differences, their CIs, and P values correspond to marginal
differences from the linear cost models.
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In addition, southeast PACCI pilot practices had neither
direct incentives to contain costs nor feedback on their patients’
utilization of care. Possibly as a consequence of these fea-
tures of pilot design, we found that few pilot practices in-
creased their night and weekend access capabilities, which
could, in theory, have produced short-term savings by offer-
ing patients an alternative to more expensive sites of care (such
as hospital emergency departments).
Several reasons may explain the limited (or absent)
changes in quality, utilization, and costs of care that we
observed, despite structural transformation among pilot
practices. First, pilot practices were volunteers and may
have been more quality-conscious than other practices, per-
forming closer to their optimal levels at baseline. If so, “ceil-
ing effects” resulting from near-optimal performance would
imply that an average practice developing a medical home
structure might show greater improvement than what we
observed. Therefore, our findings may not generalize to
other medical home interventions. Second, the structural
survey response rate among comparison practices was low,
so we cannot tell whether comparison practices were also
transforming during the pilot (eg, due to federal incentives
to adopt EHRs). Simultaneous transformation would
weaken the ability of pilot practices to differentiate them-
selves from comparison practices. Third, prior cross-
sectional research suggests that relationships between
structural capabilities, NCQA recognition, and performance
on measures of quality and utilization are modest.40-42 The
elements of practice transformation necessary to produce
desired changes in patient care may be different from the
capabilities assessed commonly by research surveys and
certification tools.
Our study has limitations. First, pilot and comparison prac-
tices were not matched perfectly. Although propensity weight-
ing and multiple regression can account for observed differ-
ences, unobserved differences could have introduced
confounding. Second, failure to find statistically significant re-
sults for most diabetes measures may have resulted from in-
sufficient power to detect performance improvement differ-
ences smaller than approximately 8 percentage points. Third,
the baseline structural survey was retrospective, with poten-
tial respondent recall error. Fourth, we were unable to exam-
ine changes in patient experience.
Conclusions
One of the first, largest, and longest-running multipayer medi-
cal home pilots in the United States, in which participating prac-
tices adopted new structural capabilities and received NCQA
Table 5. Propensity-Weighted, Adjusted Rates of Multiple Hospital and ED Use in Each Year Among
Continuously Enrolled Patients Attributed to Pilot and Comparison Practicesa
No. (%)b
12 mo Prior to
Intervention Year 1 Year 2 Year 3
2 Hospitalizations
within year, all-cause
Pilot 554 (1.4) 561 (1.4) 529 (1.3) 480 (1.2)
Comparison 563 (1.4) 471 (1.2) 504 (1.3) 414 (1.0)
OR (95% CI) NAc 1.22
(0.89-1.68)
1.07
(0.76-1.50)
1.18
(0.84-1.67)
P value NA .22 .70 .34
≥3 Hospitalizations
within year, all-cause
Pilot 320 (0.81) 358 (0.91) 385 (0.97) 386 (0.98)
Comparison 325 (0.81) 337 (0.84) 354 (0.88) 353 (0.88)
OR (95% CI) NA 1.09
(0.83-1.42)
1.12
(0.82-1.51)
1.12
(0.79-1.60)
P value NA .54 .48 .52
2 ED visits within year,
all-cause
Pilot 1977 (5.0) 2255 (5.7) 2305 (5.8) 2132 (5.4)
Comparison 2012 (5.0) 2344 (5.8) 2410 (6.0) 2161 (5.4)
OR (95% CI) NA 1.00
(0.90-1.10)
0.99
(0.89-1.11)
1.01
(0.88-1.17)
P value NA .96 .89 .86
≥3 ED visits within
year, all-cause
Pilot 2018 (5.1) 2267 (5.7) 2271 (5.7) 2099 (5.3)
Comparison 2052 (5.1) 2616 (6.5) 2562 (6.4) 2240 (5.6)
OR (95% CI) NA 0.85
(0.71-1.02)
0.88
(0.73-1.06)
0.93
(0.74-1.17)
P value NA .09 .17 .54
Abbreviations: ED, emergency
department; NA, not applicable; OR,
odds ratio.
a The number of patients contributing
data from pilot practices was 39 559
and from comparison practices,
40 234, in the preintervention
period; these patients had
continuous enrollment in their health
plan during the study period.
b Point estimates are
propensity-weighted recycled
predictions from logistic regression
models adjusting for baseline
utilization rates; patient sex, age,
and Charlson comorbidity score;
health plan contributing each
observation; and whether each
patient was in a health maintenance
organization at the time of the
observation. Frequencies are
calculated from adjusted, weighted
percentages based on the
denominators for each measure.
Odds ratios, CIs, and P values reflect
marginal differences between pilot
and comparison in each
intervention year.
c Because of the inclusion of fixed
effects for practices, regression
models do not estimate
preintervention differences
between pilot and comparison.
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certification, was associated with limited improvements in
quality and was not associated with reductions in utilization
of hospital, emergency department, or ambulatory care ser-
vices or total costs of care over 3 years. These findings sug-
gest that medical home interventions may need further re-
finement.
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